Concepedia

C. Villena

CV

Statistics

Publications

4

Citations

231

H-Index

4

Active since

1998

Affiliations

Klinikum Mittelbaden(Current)

University Medical Center Hamburg-Eppendorf

Universität Hamburg

C. Villena is an author at Klinikum Mittelbaden specializing in breast cancer, medicine, and cancer therapeutics.

Top concepts

MedicineBreast CancerOncologyCancer TherapyPathologyImmunologyPharmacologyTumor BiologyCancer GeneticsClinical Trials

Publications per year

1998–2011

4

Publications

4

Expression ofSSX genes in human tumors

Özlem Türeci, Yao‐Tseng Chen, Uğur Şahin et al. · International Journal of Cancer · 1998 · 179 citations · Full text

Human Tumors, Tumor Biology, Cancer Immunosurveillance +14

CD24 Ala57Val polymorphism predicts pathologic complete response to sequential anthracycline- and taxane-based neoadjuvant chemotherapy for primary breast cancer

Frederik Marmé, Wiebke Werft, Anne Walter et al. · Breast Cancer Research and Treatment · 2011 · 23 citations

Breast Oncology, Pathologic Complete Response, Medicine +10

Phase II trial of vinorelbine and trastuzumab in patients with HER2-positive metastatic breast cancer. A prospective, open label, non-controlled, multicenter phase II trial (to investigate efficacy and safety of this combination chemotherapy)

Georgia Schilling, M. Bruweleit, Nadia Harbeck et al. · Investigational New Drugs · 2008 · 17 citations

Breast Oncology, Phase Ii Trial, Combination Chemotherapy +8

Interim results of a prospective, open-label, multicentre phase II trial of the efficacy and safety of vinorelbine (N) and trastuzumab (H) in patients with HER2-positive metastatic breast cancer (MBC)

Maike de Wit, Nadia Harbeck, Christoph Thomssen et al. · Journal of Clinical Oncology · 2004 · 12 citations

Synergistic Activity, Breast Oncology, Cardiovascular Disease +13

1–4 of 4